State Street Corp Immunovant, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Immunovant, Inc. stock. As of the latest transaction made, State Street Corp holds 3,022,342 shares of IMVT stock, worth $83.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,022,342

Previous 2,718,956 11.16%

Holding current value

$83.1 Million

Previous $71.8 Million 15.83%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.51 - $27.51 $8.35 Million - $8.35 Million	303,386 Added 11.16%	3,022,342 $83.1 Million
Q2 2024 Aug 14, 2024	SELL	$25.1 - $31.61 $23.2 Million - $29.2 Million	-922,951 Reduced 25.34%	2,718,956 $71.8 Million
Q1 2024 May 15, 2024	BUY	$30.27 - $43.79 $12.9 Million - $18.6 Million	425,531 Added 13.23%	3,641,907 $118 Million
Q4 2023 Feb 14, 2024	SELL	$31.31 - $44.19 $7.9 Million - $11.1 Million	-252,241 Reduced 7.27%	3,216,376 $136 Million
Q3 2023 Nov 14, 2023	BUY	$18.55 - $39.96 $4.35 Million - $9.37 Million	234,448 Added 7.25%	3,468,617 $133 Million
Q2 2023 Aug 14, 2023	SELL	$14.2 - $23.75 $10.4 Million - $17.4 Million	-733,436 Reduced 18.49%	3,234,169 $61.4 Million
Q1 2023 May 15, 2023	BUY	$15.27 - $19.72 $13.1 Million - $16.9 Million	854,662 Added 27.46%	3,967,605 $61.5 Million
Q4 2022 Feb 14, 2023	BUY	$6.59 - $17.75 $14.7 Million - $39.7 Million	2,234,342 Added 254.31%	3,112,943 $55.3 Million
Q3 2022 Nov 15, 2022	SELL	$3.93 - $6.37 $55,330 - $89,683	-14,079 Reduced 1.58%	878,601 $4.9 Million
Q2 2022 Aug 15, 2022	BUY	$3.38 - $5.65 $192,450 - $321,699	56,938 Added 6.81%	892,680 $3.48 Million
Q1 2022 May 16, 2022	SELL	$5.06 - $8.77 $9.85 Million - $17.1 Million	-1,947,052 Reduced 69.97%	835,742 $4.61 Million
Q4 2021 Feb 14, 2022	SELL	$7.33 - $9.32 $9.74 Million - $12.4 Million	-1,329,000 Reduced 32.32%	2,782,794 $23.7 Million
Q3 2021 Nov 15, 2021	SELL	$7.01 - $11.37 $1.95 Million - $3.17 Million	-278,843 Reduced 6.35%	4,111,794 $35.7 Million
Q2 2021 Aug 16, 2021	BUY	$9.4 - $16.85 $7.28 Million - $13.1 Million	774,877 Added 21.43%	4,390,637 $46.4 Million
Q1 2021 May 17, 2021	BUY	$13.08 - $49.6 $22.8 Million - $86.6 Million	1,746,740 Added 93.46%	3,615,760 $58 Million
Q4 2020 Feb 16, 2021	BUY	$36.36 - $52.71 $26.1 Million - $37.8 Million	717,555 Added 62.32%	1,869,020 $86.3 Million
Q3 2020 Nov 10, 2020	BUY	$22.61 - $38.9 $18.5 Million - $31.9 Million	819,890 Added 247.27%	1,151,465 $40.5 Million
Q2 2020 Aug 14, 2020	BUY	$13.87 - $28.44 $4.6 Million - $9.43 Million	331,575 New	331,575 $8.07 Million

Others Institutions Holding IMVT

# of Institutions

211

Shares Held

66M

Call Options Held

2.3M

Put Options Held

631K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Immunovant, Inc. Transaction History